Ultragenyx Pharmaceutical (RARE) EBT (QoQ) (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) EBT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 2.72 Bn | 2.31 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.21% |
| Dec 31, 2025 | 32.22% |
| Sep 30, 2025 | -57.49% |
| Jun 30, 2025 | 24.00% |
| Mar 31, 2025 | -16.44% |
| Dec 31, 2024 | 3.30% |
| Sep 30, 2024 | -1.89% |
| Jun 30, 2024 | 23.20% |
| Mar 31, 2024 | -33.59% |
| Dec 31, 2023 | 19.86% |
| Sep 30, 2023 | 0.06% |
| Jun 30, 2023 | 2.68% |
| Mar 31, 2023 | -6.65% |
| Dec 31, 2022 | 35.82% |
| Sep 30, 2022 | -51.29% |
| Jun 30, 2022 | -4.02% |
| Mar 31, 2022 | -145.59% |
| Dec 31, 2021 | 557.15% |
| Sep 30, 2021 | 40.30% |
| Jun 30, 2021 | 10.16% |